Filing Details

Accession Number:
0000950170-23-047302
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-08 16:44:26
Reporting Period:
2023-09-06
Accepted Time:
2023-09-08 16:44:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1661998 Homology Medicines Inc. FIXX Pharmaceutical Preparations (2834) 473468154
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1735324 Albert Seymour C/O Homology Medicines, Inc.
One Patriots Park
Bedford MA 01730
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-06 4,620 $0.00 152,322 No 4 M Direct
Common Stock Disposition 2023-09-06 1,448 $1.15 150,874 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2023-09-06 4,620 $0.00 4,620 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,380 No 4 M Direct
Footnotes
  1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
  2. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs.
  3. The RSUs will vest and settle as to one third of the RSUs on each of the first three anniversaries of September 6, 2022 so that such RSUs will become fully vested on September 6, 2025. The RSUs have no expiration date.